Maximise your day
NEW Maxofen from Nova Pharmaceuticals combines paracetamol and ibuprofen for double-action relief from acute pain and fever. Available in packs…
No CVD benefit from daily aspirin
HEALTHY older adults who take a low-dose of aspirin daily may experience a higher risk of a major haemorrhage without…
Educating patients on pain
WITH new regulations around the scheduling of paracetamol pack sizes and the down-scheduling of COX-2 inhibitors coming in this year,…
Issue Information
No abstract is available for this article.
Video: APhA Advocacy Strengthens Pharmacists’ Role in Expanding Vaccine Access
Allison Hill, PharmD, RPh, discusses how rapid changes in vaccine schedules and state-level authority highlight the importance of the American…
Understanding Cannabis-Linked Paranoia: Motives, Trauma, and Clinical Implications
Research shows that individuals who use cannabis to self-medicate, especially those with a history of childhood trauma, face heightened risks…
CMS Tech Company Pledge – Healthcare IT Today Podcast Episode 174
The 174th episode of the Healthcare IT Today Podcast is sponsored by Swaay.Health, be sure to join us at the Swaay.Health…
AI in Healthcare Is Moving Fast. The Infrastructure to Govern It Isn’t.
The following is a guest article by Daniel Vreeman, DPT, Chief Standards Development Officer and Chief AI Officer at HL7…
Mitochondria-Targeted Therapies May Transform Acute Kidney Injury Treatment
Future research should focus on optimizing drug design, mitochondrial biogenesis regulation, and establishment of treatments for acute kidney injury (AKI).